Old Web
English
Sign In
Acemap
>
authorDetail
>
Shanmugasundaram Ramkumar
Shanmugasundaram Ramkumar
University Hospital Southampton NHS Foundation Trust
Oncology
Internal medicine
Carcinoma
Nivolumab
Cetuximab
3
Papers
82
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Review on the Cellular Mechanisms of Low-Level Laser Therapy Use in Oncology
2020
Frontiers in Oncology
Shing-yau Tam
Victor C. W. Tam
Shanmugasundaram Ramkumar
May Ling Khaw
Helen K. W. Law
Shara W. Y. Lee
Show All
Source
Cite
Save
Citations (8)
Nivolumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
2019
Clinical Cancer Research
Robert L. Ferris
Lisa Licitra
Jérôme Fayette
Caroline Even
George R. Blumenschein
Kevin J. Harrington
Joel Guigay
Everett E. Vokes
Nabil F. Saba
Robert I. Haddad
Shanmugasundaram Ramkumar
Jeffery S. Russell
Peter Brossart
Makoto Tahara
A. Dimitrios Colevas
Fernando Concha-Benavente
Mark Lynch
Li Li
Maura L. Gillison
Show All
Source
Cite
Save
Citations (60)
Nivolumab (Nivo) vs investigator’s choice (IC) in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety in CheckMate 141 by prior cetuximab use.
2017
Journal of Clinical Oncology
Robert L. Ferris
Lisa Licitra
Jérôme Fayette
Caroline Even
George R. Blumenschein
Kevin J. Harrington
J. Guigay
Everett E. Vokes
Nabil F. Saba
Robert I. Haddad
Shanmugasundaram Ramkumar
Jeffrey Russell
Peter Brossart
Makoto Tahara
Manish Monga
Jin Zhu
A. Dimitrios Colevas
Maura L. Gillison
Show All
Source
Cite
Save
Citations (14)
1